Cargando…
The homologous recombination protein RAD51 is a promising therapeutic target for cervical carcinoma
RAD51 is one of the pivotal enzymes for DNA double-strand break (DSB) repair by the homologous recombination (HR) pathway, which implies it as a promising and novel target for cancer therapy. Recent findings have indicated RAD51 protein is overexpressed in a variety of tumors. The high-expression of...
Autores principales: | Chen, Qian, Cai, Dongge, Li, Mu, Wu, Xiaoling |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5561999/ https://www.ncbi.nlm.nih.gov/pubmed/28627709 http://dx.doi.org/10.3892/or.2017.5724 |
Ejemplares similares
-
OTUB2 Promotes Homologous Recombination Repair Through Stimulating Rad51 Expression in Endometrial Cancer
por: Wan, Qiuyuan, et al.
Publicado: (2020) -
Homologous recombination, cancer and the ‘RAD51 paradox’
por: Matos-Rodrigues, Gabriel, et al.
Publicado: (2021) -
Rad51 Paralogs Remodel Pre-synaptic Rad51 Filaments to Stimulate Homologous Recombination
por: Taylor, Martin R.G., et al.
Publicado: (2015) -
New RAD51 Inhibitors to Target Homologous Recombination in Human Cells
por: Shkundina, Irina S., et al.
Publicado: (2021) -
Repression of mutagenesis by Rad51D-mediated homologous recombination
por: Hinz, John M., et al.
Publicado: (2006)